Form D · Venture Capital Fund

venBio Global Strategic Fund IV, L.P.

San Francisco, CA · CIK 0001862109

Offering snapshot reported May 14, 2021 · SEC filing

Reported sold: $550M
Investors reported: 147
Minimum accepted: $125K
First sale: Apr 30, 2021

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
May 14, 2021	Initial	$549,936,000	No comparison	147	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b, 3C, 3C.1, 3C.7
Duration over one year: Yes
Business combination: No

Sales commissions: $2.44M (estimated)
Finders' fees: $0
Form D file number: 021-399537

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
BA Securities LLC	153489
Far Hills Group, LLC	32243

Source: Form D, filed May 14, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

VENBIO GLOBAL STRATEGIC FUND IV, L.P.

Investment adviser: VENBIO PARTNERS LLC

Gross asset value: $550M
Beneficial owners: 147
ADV minimum commitment: $0

Reported in Form ADV on Mar 12, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator STANDISH MANAGEMENT SAN FRANCISCO, California, United States Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor KPMG, LLP SAN FRANCISCO, California, United States

Custodian MORGAN STANLEY & CO. LLC SAN FRANCISCO, California, United States Related to adviser: No

Custodian SILICON VALLEY BANK SAN FRANCISCO, California, United States Related to adviser: No

Marketer BA SECURITIES, LLC SAN DIEGO, California, United States Related to adviser: No

Marketer FAR HILLS GROUP, LLC. NEW YORK, New York, United States Related to adviser: No

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: Yes

KPMG, LLP
PCAOB 185

MORGAN STANLEY & CO. LLC
SEC 8-15869

SILICON VALLEY BANK
LEI 0K2D5AK28E3O5CC06E35

BA SECURITIES, LLC
CRD 153489 · SEC 8-68545

FAR HILLS GROUP, LLC.
CRD 32243 · SEC 8-45675

Filing source

Form ADV 2064569 · Mar 12, 2026 · Schedule D 7.B.(1), fund 805-5073231855

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

Related funds

Funds whose names form a numbered series with this one and that share its city or the name of a related person. Form D does not state how these funds are related.

Fund	Latest Form D	Reported sold	Investors
venBio Global Strategic Fund, L.P.	Oct 29, 2013	$177,000,000	4
venBio Global Strategic Fund II L.P.	Mar 2, 2017	$337,000,000	31
venBio Global Strategic Fund III, L.P.	Mar 26, 2020	$386,055,000	100
venBio Global Strategic Fund IV, L.P. (this fund)	May 14, 2021	$549,936,000	147
venBio Global Strategic Fund V, L.P.	Jul 12, 2024	$504,700,000	162

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Robert Adelman	Executive
Richard Gaster	Executive
Corey Goodman	Executive
David Pezeshki	Executive
Aaron Royston	Executive
N/A Ven Bio Global Strategic Gp Iv, Llc	Promoter
N/A Ven Bio Management Company Llc	Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

1700 Owens Street, Suite 595
San Francisco, CA, 94158